{
    "organizations": [],
    "uuid": "97a1282e4bed85d064c33fb97f5f261ab83e1821",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ironwood-pharmaceuticals-sees-us-n/brief-ironwood-pharmaceuticals-sees-u-s-net-sales-of-linzess-of-about-700-million-for-fy-ended-dec-31-2017-idUSFWN1P30TP",
    "ord_in_thread": 0,
    "title": "BRIEF-Ironwood Pharmaceuticals Sees U.S. Net Sales Of Linzess Of About $700 Million‍​ For FY Ended Dec 31, 2017",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "#Market News January 8, 2018 / 4:53 PM / Updated 38 minutes ago BRIEF-Ironwood Pharmaceuticals Sees U.S. Net Sales Of Linzess Of About $700 Million‍​ For FY Ended Dec 31, 2017 Reuters Staff 1 Min Read \nJan 8 (Reuters) - Ironwood Pharmaceuticals Inc: \n* IRONWOOD PHARMACEUTICALS INC - EXPECTED U.S. NET SALES OF LINZESS (LINACLOTIDE) OF ABOUT $700 MILLION‍​ FOR FY ENDED DEC 31, 2017 \n* IRONWOOD PHARMACEUTICALS - ‍EXPECTED IRONWOOD REVENUE FROM LINACLOTIDE API SALES TO ASTELLAS OF MORE THAN $100 MILLION FROM JAN 1, 2017 TO DEC 31, 2019​ \n* IRONWOOD PHARMACEUTICALS- EXPECTED REVENUE CAGR FROM THE LINZESS U.S. COLLABORATION WITH ALLERGAN OF ABOUT 75% FOR YEAR ENDED DEC 31, 2014 TO 2017 \n* IRONWOOD PHARMACEUTICALS- EXPECTED LINZESS U.S. NET SALES CAGR OF GREATER THAN 30% FOR YEAR ENDED DEC 31, 2014 TO YEAR ENDED DECEMBER 31, 2017 Source text : ( bit.ly/2CQ3Ise ) Further company coverage:",
    "published": "2018-01-09T00:53:00.000+02:00",
    "crawled": "2018-01-08T19:26:24.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "see",
        "net",
        "sale",
        "linzess",
        "fy",
        "ended",
        "dec",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "ironwood",
        "pharmaceutical",
        "inc",
        "ironwood",
        "pharmaceutical",
        "inc",
        "expected",
        "net",
        "sale",
        "linzess",
        "linaclotide",
        "fy",
        "ended",
        "dec",
        "ironwood",
        "pharmaceutical",
        "ironwood",
        "revenue",
        "linaclotide",
        "api",
        "sale",
        "astellas",
        "million",
        "jan",
        "dec",
        "ironwood",
        "expected",
        "revenue",
        "cagr",
        "linzess",
        "collaboration",
        "allergan",
        "year",
        "ended",
        "dec",
        "ironwood",
        "expected",
        "linzess",
        "net",
        "sale",
        "cagr",
        "greater",
        "year",
        "ended",
        "dec",
        "year",
        "ended",
        "december",
        "source",
        "text",
        "company",
        "coverage"
    ]
}